Cancer Genetics and Epigenetics 2024, Vol.12, No.3, 115-124 http://medscipublisher.com/index.php/cge 123 Calcagno D.Q., Gigek C.O., Chen E.S., Burbano R.R., and Smith M.D.A.C., 2013, DNA and histone methylation in gastric carcinogenesis, World Journal of Gastroenterology: WJG, 19(8): 1182. https://doi.org/10.3748/wjg.v19.i8.1182 Canale M., Casadei-Gardini A., Ulivi P., Arechederra M., Berasain C., Lollini P.L., Fernández-Barrena M., and Avila M.A., 2020, Epigenetic mechanisms in gastric cancer: potential new therapeutic opportunities, International Journal of Molecular Sciences, 21(15): 5500. https://doi.org/10.3390/ijms21155500 Capparelli R., and Iannelli D., 2022, Epigenetics and helicobacter pylori, International Journal of Molecular Sciences, 23(3): 1759. https://doi.org/10.3390/ijms23031759 Crispo F., Condelli V., Lepore S., Notarangelo T., Sgambato A., Esposito F., Maddalena F., and Landriscina M., 2019, Metabolic dysregulations and epigenetics: a bidirectional interplay that drives tumor progression, Cells, 8(8): 798. https://doi.org/10.3390/cells8080798 Dawson M.A., and Kouzarides T., 2012, Cancer epigenetics: from mechanism to therapy, Cell, 150(1): 12-27. https://doi.org/10.1016/j.cell.2012.06.013 Ebrahimi V., Soleimanian A., Ebrahimi T., Azargun R., Yazdani P., Eyvazi S., and Tarhriz V., 2020, Epigenetic modifications in gastric cancer: focus on DNA methylation, Gene, 742: 144577. https://doi.org/10.1016/j.gene.2020.144577 Flavahan W.A., Gaskell E., and Bernstein B.E., 2017, Epigenetic plasticity and the hallmarks of cancer, Science, 357(6348): eaal2380. https://doi.org/10.1126/science.aal2380 Grady W.M., 2021, Epigenetic alterations in the gastrointestinal tract: current and emerging use for biomarkers of cancer, Advances in Cancer Research, 151: 425-468. https://doi.org/10.1016/bs.acr.2021.02.006 Jin G., Lv J., Yang M., Wang M., Zhu M., Wang T., Yan C., Yu C., Ding Y., Li G., Ren C., Ni J., Zhang R., Guo Y., Bian Z., Zheng Y., Zhang N., Jiang Y., Chen J., Wang Y., Xu D., Zheng H., Yang L., Chen Y., Walters R., Millwood I., Dai J., Ma H., Chen K., Chen Z., Hu Z., Wei Q., Shen H., and Li L., 2020, Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study, The Lancet Oncology, 21(10): 1378-1386. https://doi.org/10.1016/S1470-2045(20)30460-5 Jin N., George T.L., Otterson G.A., Verschraegen C., Wen H., Carbone D., Herman J., Bertino E., and He K., 2021, Advances in epigenetic therapeutics with focus on solid tumors, Clinical Epigenetics, 13: 1-27. https://doi.org/10.1186/s13148-021-01069-7 Kagohara L.T., Stein-O'Brien G.L., Kelley D., Flam E., Wick H.C., Danilova L.V., Easwaran H., Favorov A., Qian J., Gaykalova D., and Fertig E.J., 2018, Epigenetic regulation of gene expression in cancer: techniques, resources and analysis, Briefings in Functional Genomics, 17(1): 49-63. https://doi.org/10.1093/bfgp/elx018 Kang C., Song J.J., Lee J., and Kim M.Y., 2014, Epigenetics: an emerging player in gastric cancer, World Journal of Gastroenterology: WJG, 20(21): 6433. https://doi.org/10.3748/wjg.v20.i21.6433 Kang S.K., Kim T.S., Kwon W.S., Roh J.K., Lim H.Y., Chun H.C., and Rha S.Y., 2017, Inhibition of BET bromodomain, epigenetic regulator, as an effective therapeutic approach for gastric cancer, Cancer Research, 77(13_Supplement): 5069. https://doi.org/10.1158/1538-7445.AM2017-5069 Khorasani A.B.S., Pourbagheri-Sigaroodi A., Pirsalehi A., Safaroghli-Azar A., Zali M.R., and Bashash D., 2021, The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions, European Journal of Pharmacology, 898: 173983. https://doi.org/10.1016/j.ejphar.2021.173983 Lee S., Yang H.K., Lee H.J., Park D.J., Kong S.H., and Park S.K., 2022, Systematic review of gastric cancer-associated genetic variants, gene-based meta-analysis, and gene-level functional analysis to identify candidate genes for drug development, Frontiers in Genetics, 13: 928783. https://doi.org/10.3389/fgene.2022.928783 Naeli P., Pourhanifeh M.H., Karimzadeh M.R., Shabaninejad Z., Movahedpour A., Tarrahimofrad H., Mirzaei H., Bafrani H., Savardashtaki A., Mirzaei H., and Hamblin M.R., 2020, Circular RNAs and gastrointestinal cancers: epigenetic regulators with a prognostic and therapeutic role, Critical Reviews in Oncology/Hematology, 145: 102854. https://doi.org/10.1016/j.critrevonc.2019.102854 Nemtsova M.V., Kalinkin A.I., Kuznetsova E.B., Bure I.V., Alekseeva E.A., Bykov I.I., Khorobrykh T., Mikhaylenko D., Tanas A., and Strelnikov V.V., 2021, Mutations in epigenetic regulation genes in gastric cancer, Cancers, 13(18): 4586. https://doi.org/10.3390/cancers13184586 Otani K., Li X., Arakawa T., Chan F.K., and Yu J., 2013, Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer, Expert Review of Molecular Diagnostics, 13(5): 445. https://doi.org/10.1586/erm.13.32 Perri F., Longo F., Giuliano M., Sabbatino F., Favia G., Ionna F., Ionna F., Addeo R., Scarpati G., Lorenzo G., and Pisconti S., 2017, Epigenetic control of gene expression: potential implications for cancer treatment, Critical Reviews in Oncology/Hematology, 111: 166-172. https://doi.org/10.1016/j.critrevonc.2017.01.020 Puneet, Kazmi H.R., Kumari S., Tiwari S., Khanna A., and Narayan G., 2018, Epigenetic mechanisms and events in gastric cancer-emerging novel biomarkers, Pathology and Oncology Research, 24: 757-770. https://doi.org/10.1007/s12253-018-0410-z
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==